Freedom Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,148
| Closed | -$603K | – | 559 |
|
|
2025
Q2 | $603K | Buy |
1,148
+66
| +6% | +$36.8K | 0.05% | 386 |
|
|
2025
Q1 | $686K | Buy |
1,082
+277
| +34% | +$191K | 0.06% | 339 |
|
|
2024
Q4 | $574K | Buy |
805
+49
| +6% | +$41.1K | 0.05% | 387 |
|
|
2024
Q3 | $795K | Sell |
756
-118
| -14% | -$131K | 0.06% | 309 |
|
|
2024
Q2 | $919K | Sell |
874
-60
| -6% | -$58.2K | 0.08% | 257 |
|
|
2024
Q1 | $899K | Sell |
934
-520
| -36% | -$494K | 0.07% | 274 |
|
|
2023
Q4 | $1.28M | Sell |
1,454
-22
| -1% | -$18.1K | 0.1% | 182 |
|
|
2023
Q3 | $1.21M | Sell |
1,476
-139
| -9% | -$109K | 0.15% | 162 |
|
|
2023
Q2 | $1.16M | Sell |
1,615
-501
| -24% | -$386K | 0.13% | 202 |
|
|
2023
Q1 | $1.74M | Sell |
2,116
-78
| -4% | -$58.8K | 0.2% | 131 |
|
|
2022
Q4 | $1.58M | Sell |
2,194
-9
| -0.4% | -$6.64K | 0.18% | 150 |
|
|
2022
Q3 | $1.52M | Buy |
2,203
+232
| +12% | +$146K | 0.18% | 144 |
|
|
2022
Q2 | $1.17M | Sell |
1,971
-141
| -7% | -$91.7K | 0.12% | 233 |
|
|
2022
Q1 | $1.48M | Buy |
2,112
+213
| +11% | +$135K | 0.13% | 200 |
|
|
2021
Q4 | $1.2M | Buy |
1,899
+49
| +3% | +$30.1K | 0.09% | 294 |
|
|
2021
Q3 | $1.12M | Sell |
1,850
-82
| -4% | -$50.9K | 0.09% | 299 |
|
|
2021
Q2 | $1.08M | Sell |
1,932
-60
| -3% | -$30.4K | 0.08% | 305 |
|
|
2021
Q1 | $942K | Sell |
1,992
-1,160
| -37% | -$565K | 0.07% | 319 |
|
|
2020
Q4 | $1.52M | Sell |
3,152
-947
| -23% | -$511K | 0.17% | 132 |
|
|
2020
Q3 | $2.29M | Buy |
4,099
+132
| +3% | +$80K | 0.25% | 83 |
|
|
2020
Q2 | $2.47M | Sell |
3,967
-894
| -18% | -$507K | 0.27% | 78 |
|
|
2020
Q1 | $1.86M | Buy |
4,861
+80
| +2% | +$33K | 0.16% | 129 |
|
|
2019
Q4 | $1.79M | Sell |
4,781
-484
| -9% | -$163K | 0.16% | 137 |
|
|
2019
Q3 | $1.46M | Sell |
5,265
-881
| -14% | -$261K | 0.13% | 159 |
|
|
2019
Q2 | $1.92M | Sell |
6,146
-431
| -7% | -$143K | 0.16% | 137 |
|
|
2019
Q1 | $2.7M | Sell |
6,577
-269
| -4% | -$111K | 0.22% | 91 |
|
|
2018
Q4 | $2.56M | Sell |
6,846
-1,451
| -17% | -$531K | 0.2% | 86 |
|
|
2018
Q3 | $3.35M | Buy |
8,297
+960
| +13% | +$365K | 0.21% | 78 |
|
|
2018
Q2 | $2.53M | Buy |
7,337
+4,171
| +132% | +$1.3M | 0.15% | 116 |
|
|
2018
Q1 | $1.09M | Buy |
3,166
+75
| +2% | +$26.1K | 0.06% | 351 |
|
|
2017
Q4 | $1.16M | Buy |
3,091
+59
| +2% | +$23.9K | 0.06% | 307 |
|
|
2017
Q3 | $1.36M | Sell |
3,032
-147
| -5% | -$69.9K | 0.07% | 235 |
|
|
2017
Q2 | $1.56M | Buy |
3,179
+38
| +1% | +$16.6K | 0.09% | 177 |
|
|
2017
Q1 | $1.22M | Sell |
3,141
-407
| -11% | -$151K | 0.07% | 237 |
|
|
2016
Q4 | $1.3M | Sell |
3,548
-910
| -20% | -$346K | 0.08% | 183 |
|
|
2016
Q3 | $1.79M | Sell |
4,458
-97
| -2% | -$38.9K | 0.11% | 113 |
|
|
2016
Q2 | $1.59M | Buy |
4,555
+197
| +5% | +$75.9K | 0.11% | 115 |
|
|
2016
Q1 | $1.57M | Sell |
4,358
-674
| -13% | -$278K | 0.11% | 117 |
|
|
2015
Q4 | $2.73M | Buy |
5,032
+1,666
| +49% | +$903K | 0.21% | 54 |
|
|
2015
Q3 | $416K | Buy |
3,366
+75
| +2% | +$40.3K | 0.04% | 369 |
|
|
2015
Q2 | $1.68M | Buy |
3,291
+941
| +40% | +$459K | 0.17% | 85 |
|
|
2015
Q1 | $1.06M | Buy |
2,350
+1,152
| +96% | +$488K | 0.12% | 126 |
|
|
2014
Q4 | $492K | Buy |
+1,198
| New | +$471K | 0.06% | 291 |
|
Other funds holding REGN
